PubRank
Search
About
Fanny Dao
Author PubWeight™ 15.31
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
Gynecol Oncol
2011
2.89
2
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Sci Transl Med
2013
2.58
3
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?
Gynecol Oncol
2009
1.35
4
A microRNA survival signature (MiSS) for advanced ovarian cancer.
Gynecol Oncol
2011
1.18
5
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Gynecol Oncol
2012
1.06
6
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
Int J Gynecol Cancer
2013
1.04
7
Validated gene targets associated with curatively treated advanced serous ovarian carcinoma.
Gynecol Oncol
2012
0.93
8
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
Am J Surg Pathol
2013
0.92
9
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.
Gynecol Oncol
2011
0.87
10
Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.
Radiology
2014
0.84
11
A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.
Gynecol Oncol
2012
0.83
12
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.
Int J Gynecol Cancer
2010
0.75